| pubmed-article:19407933 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19407933 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:19407933 | lifeskim:mentions | umls-concept:C2709248 | lld:lifeskim |
| pubmed-article:19407933 | lifeskim:mentions | umls-concept:C0035608 | lld:lifeskim |
| pubmed-article:19407933 | lifeskim:mentions | umls-concept:C0011209 | lld:lifeskim |
| pubmed-article:19407933 | lifeskim:mentions | umls-concept:C1450054 | lld:lifeskim |
| pubmed-article:19407933 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
| pubmed-article:19407933 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:19407933 | pubmed:dateCreated | 2009-7-6 | lld:pubmed |
| pubmed-article:19407933 | pubmed:abstractText | To formulate rifampicin, an anti-tuberculosis antibiotic, for aerosol delivery in a dry powder 'porous nanoparticle-aggregate particle' (PNAP) form suited for shelf stability, effective dispersibility and extended release with local lung and systemic drug delivery. | lld:pubmed |
| pubmed-article:19407933 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19407933 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19407933 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19407933 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19407933 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19407933 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19407933 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19407933 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19407933 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19407933 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19407933 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19407933 | pubmed:issn | 1573-904X | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:PeloquinCharl... | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:HickeyAnthony... | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:EdwardsDavid... | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:Garcia-Contre... | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:PadillaDaniel... | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:DurbinDavidD | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:SungJean CJC | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:VerberkmoesJa... | lld:pubmed |
| pubmed-article:19407933 | pubmed:author | pubmed-author:ElbertKathari... | lld:pubmed |
| pubmed-article:19407933 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19407933 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:19407933 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19407933 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19407933 | pubmed:pagination | 1847-55 | lld:pubmed |
| pubmed-article:19407933 | pubmed:meshHeading | pubmed-meshheading:19407933... | lld:pubmed |
| pubmed-article:19407933 | pubmed:meshHeading | pubmed-meshheading:19407933... | lld:pubmed |
| pubmed-article:19407933 | pubmed:meshHeading | pubmed-meshheading:19407933... | lld:pubmed |
| pubmed-article:19407933 | pubmed:meshHeading | pubmed-meshheading:19407933... | lld:pubmed |
| pubmed-article:19407933 | pubmed:meshHeading | pubmed-meshheading:19407933... | lld:pubmed |
| pubmed-article:19407933 | pubmed:meshHeading | pubmed-meshheading:19407933... | lld:pubmed |
| pubmed-article:19407933 | pubmed:meshHeading | pubmed-meshheading:19407933... | lld:pubmed |
| pubmed-article:19407933 | pubmed:meshHeading | pubmed-meshheading:19407933... | lld:pubmed |
| pubmed-article:19407933 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19407933 | pubmed:articleTitle | Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. | lld:pubmed |
| pubmed-article:19407933 | pubmed:affiliation | Harvard School of Engineering and Applied Sciences, 29 Oxford Street, Pierce 322, Cambridge, Massachusetts 02138, USA. | lld:pubmed |
| pubmed-article:19407933 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19407933 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:19407933 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
